Pyrazolyl guanidine F1F0-atpase inhibitors and therapeutic uses thereof
US9139532B2 · kind B2 · utility
8Cited by
7References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 8, 2011 |
| Grant date | Sep 22, 2015 |
| Priority date | — |
| Expiry date | Dec 8, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides pyrazolyl guanidine compounds that inhibit F1Fo-ATPase, and methods of using pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.